The MAPS Global Town Hall on July 21, 2020 focused on the challenges arising from the global COVID-19 pandemic and the emerging opportunity for Medical Affairs to provide strategic leadership. In his opening remarks, Tamas Koncz, MD, MSc, PhD, Chief Medical Officer for Inflammation and Immunology at Pfizer, identified Evidence Generation and Dissemination as key domains within Medical Affairs to guide healthcare decision-makers. With the unique opportunity to engage in meaningful and substantial peer-to-peer relationships with healthcare professionals, Medical Affairs colleagues have a responsibility to ensure the safe and effective use of medicines, vaccines and medical devices, and are also uniquely positioned to bring actionable insights from HCPs back to the Medical Affairs, R&D and other functions. The following two talks and Q&A further explored the MA role within this ecosystem of challenge and opportunity.
Evidence Generation: Ensuring Speed and Quality During Rapid Decision-making
Attendance and engagement highlighted the need for follow-on Global Town Halls to consider the role of other Medical Affairs domains including Capabilities Development, Insight Generation, Digital Innovation, and Field Medical Affairs, thus equipping MAPS members with knowledge, tools and inspiration to fulfill the opportunity for Medical Affairs strategic leadership during the COVID-19 pandemic and beyond.
Talks were followed by a Q&A session with a distinguished panel of senior Medical Affairs and Clinical Development leaders. Due to the pleasantly challenging situation of a large number of questions submitted by an engaged audience, panelists were not able to provide real-time answers to all questions, and instead offer their insights to questions submitted during the Town Hall, as follows.